|UNITED STATES
SECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549FORM 10-Q
|-------------------------------------------------------------------------------

||X| |  | QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|--- |  | ---------------------------------------------------------------------------------------

|For the quarterly
period ended September 30, 2000


OR
|------------------------------------------------------

||_| |  | TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|--- |  | ----------------------------------------------------------------------------------------

|For the transition
period from _________ to _________


Commission File Number:
1-10768



MEDIWARE INFORMATION
SYSTEMS, INC.(Exact name of registrant as specified in its charter)
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|New York(State or other jurisdiction ofIncorporation or organization) | 11-2209324(I.R.S. EmployerIdentification No.)
|--------------------------------------------------------------------- | ---------------------------------------------

|11711 West 79th StreetLenexa, Kansas(Address of principal executive offices) | 66214(Zip Code)
|---------------------------------------------------------------------------- | ---------------

|(913) 307-1000
(Registrants telephone number including area code)


(Former
name, former
address and former fiscal year, if changed since last report)




Indicate by check mark whether the
registrant (1) has filed all documents and reports required to be filed by Sections 12,
13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past 90 days. Yes [X] No [_]


As of November 7, 2000, there were
7,137,054 shares of Common Stock, $0.10 par value, of the registrant outstanding.
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

|MEDIWARE INFORMATION
SYSTEMS, INC.

INDEX
|-----------------------------------------

|                                                                      | Page
|--------------------------------------------------------------------- | ----
|PART I   Financial Information                                        |     
|ITEM 1.   Financial Statements                                        |     
|Consolidated Balance Sheets as of
September 30, 2000                  |     
|(Unaudited) and June 30, 2000
(Audited)                               |     
|Consolidated Statements of Operations                                 |     
|For the three months ended September
30, 2000 and 1999 (Unaudited)    |     
|Consolidated Statement of Cash Flows                                  |     
|For the three months ended September
30, 2000 and 1999 (Unaudited)    |     
|Notes to Financial Statements                                         |     
|Independent Accountants Report                                       |     
|ITEM 2.   Managements Discussion and Analysis of Financial           |     
|Condition and Results of Operations                                   |     
|ITEM 3.   Quantitative and Qualitative Disclosures About Market Risks |     
|PART II   Other Information                                           |     
|ITEM 6.   Exhibits and Reports on Form 8-K                            |     
|Signature Page                                                        |     

---

|MEDIWARE INFORMATION
SYSTEMS, INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS(Amounts in thousands, except
shares)
|-------------------------------------------------------------------------------------------------------------------

|                                                              | September 30,2000 | June 30,2000
|------------------------------------------------------------- | ----------------- | ------------
|
|ASSETS                                                        |                   |             
|Current Assets                                                |                  
|Cash and cash equivalents                                     |                   | $   1,679   
|Accounts receivable (net of allowance of $580 at              |                  
|September 30, 2000 and $518 at June 30, 2000)                 |                   | 5,788       
|Inventories                                                   |                   | 238         
|Prepaid expenses and other current assets                     |                   | 422         
|                                                             
|Total current assets                                          |                   | 8,127       
|                                                             
|Fixed assets, net                                             |                   | 2,317       
|Capitalized software costs, net                               |                   | 8,620       
|Goodwill, net                                                 |                   | 5,601       
|Purchased technology, net                                     |                   | 1,582       
|Deferred tax asset                                            |                   | 1,661       
|Other long-term assets                                        |                   | 151         
|                                                             
|Total Assets                                                  |                   | $ 28,059    
|                                                             
|LIABILITIES AND STOCKHOLDERS EQUITY                          |                  
|Current Liabilities                                           |                  
|Notes payable and current portion of long-term debt           |                   | $      436  
|Accounts payable                                              |                   | 1,384       
|Advances from customers                                       |                   | 5,939       
|Accrued expenses and other current liabilities                |                   | 2,851       
|                                                             
|Total current liabilities                                     |                   | 10,610      
|Notes payable and accrued interest payable to a related party |                   | 1,253       
|                                                             
|Total liabilities                                             |                   | 11,863      
|                                                             
|Stockholders Equity                                          |                  
|Preferred stock, $.01 par value; authorized 10,000,000        |                  
|shares; none issued or outstanding                            |                   |            
|Common stock, $.10 par value; authorized 12,000,000           |                  
|shares; issued and outstanding; 7,137,000 shares at           |                  
|September 30, 2000 and 7,088,000 at June 30, 2000             |                   | 714         
|Additional paid-in capital                                    |                   | 22,887      
|Accumulated deficit                                           |                   | (7,365      
|Accumulated other comprehensive (loss)                        |                   | (40         
|                                                             
|Total stockholders equity                                    |                   | 16,196      
|                                                             
|Total Liabilities and Stockholders Equity                    |                   | $ 28,059    
|                                                             

|See Notes to
Consolidated Financial Statements.
|-----------------------------------------------

---

|MEDIWARE INFORMATION
SYSTEMS, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE
INCOME(Unaudited)(Amounts in thousands, except per share amounts)
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|                                                  | Three Months Ended September 30,
|------------------------------------------------- | --------------------------------
|
|Revenues                                          |                                 
|System sales                                      |                                 
|Services                                          |                                 
|                                                 
|Total revenues                                    |                                 
|                                                 
|Cost and Expenses                                 |                                 
|Cost of systems                                   |                                 
|Cost of services                                  |                                 
|Software development costs                        |                                 
|Selling, general and administrative               |                                 
|                                                 
|Total costs and expenses                          |                                 
|                                                 
|Operating income (loss)                           |                                 
|Interest and other income                         |                                 
|Interest (expense)                                |                                 
|                                                 
|Earnings (loss) before provision for income taxes |                                 
|Benefit (provision) for income taxes              |                                 
|                                                 
|Net Earnings (Loss)                               |                                 
|                                                 
|Other Comprehensive Income, net of tax            |                                 
|Foreign currency translation adjustment           |                                 
|                                                 
|Comprehensive Income (Loss)                       |                                 
|                                                 
|Earnings (Loss) Per Common Share                  |                                 
|Basic                                             |                                 
|                                                 
|Diluted                                           |                                 
|                                                 
|Weighted Average Common Shares Outstanding        |                                 
|Basic                                             |                                 
|                                                 
|Diluted                                           |                                 
|                                                 

|See Notes to
Consolidated Financial Statements.
|-----------------------------------------------

---

|MEDIWARE INFORMATION
SYSTEMS, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENT OF CASH FLOWSFor the Three Months
Ended September 30,(Amounts in thousands)
|-----------------------------------------------------------------------------------------------------------------------------------------------------

|                                                    | 2000 | 1999    
|--------------------------------------------------- | ---- | --------
|
|Cash Flows From Operating Activities                |      |         
|Net earnings (loss)                                 |      | $  (310 
|Adjustments to reconcile net earnings (loss) to     |     
|net cash provided by operating activities:          |     
|Depreciation and amortization                       |      | 771     
|Deferred tax benefit                                |      | (207    
|Shares issued to directors                          |      | 25      
|Compensatory stock options                          |      |        
|Loss on disposal of fixed assets                    |      | 7       
|Provision for doubtful accounts                     |      | 118     
|Changes in operating assets and liabilities:        |     
|Accounts receivable                                 |      | (109    
|Inventories                                         |      | (24     
|Prepaid and other current assets                    |      | (72     
|Accounts payable, accrued expenses and              |     
|customer advances                                   |      | (711    
|                                                   
|Net cash (used in) provided by operating activities |      | (512    
|                                                   
|Cash Flows From Investing Activities                |     
|Acquisition of fixed assets, net of disposals       |      | (312    
|Capitalized software costs                          |      | (1,218  
|                                                   
|Net cash used in investing activities               |      | (1,530  
|                                                   
|Cash Flows From Financing Activities                |     
|Repayment of debt                                   |      |        
|Proceeds from exercise of options                   |      | 103     
|Other                                               |      |        
|                                                   
|Net cash provided by (used in) financing activities |      | 103     
|                                                   
|Foreign currency translation adjustments            |      | (16     
|                                                   
|Net Increase in cash and cash equivalents           |      | (1,955  
|Cash and cash equivalents at beginning of year      |      | 3,634   
|                                                   
|Cash and cash equivalents at end of year            |      | $ 1,679 
|                                                   
|Supplemental disclosures of cash flow information:  |     
|Cash paid during the period for:                    |     
|Interest                                            |      | $      
|Income taxes                                        |      | $      

|See Notes to
Consolidated Financial Statements.
|-----------------------------------------------

---

|MEDIWARE INFORMATION
SYSTEMS, INC., AND SUBSIDIARIESNOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS



1. FINANCIAL STATEMENTS



In the opinion of management, the
accompanying unaudited, consolidated, condensed financial statements contain all
adjustments necessary to present fairly the financial position of the Company and its
results of operations and cash flows for the interim periods presented. Such financial
statements have been condensed in accordance with the applicable regulations of the
Securities and Exchange Commission (SEC) and therefore, do not include all disclosures
required by generally accepted accounting principles. These financial statements should
be read in conjunction with the Companys audited financial statements for the year ended
June 30, 2000 included in the Companys annual report filed on Form 10-K.


The results of operations for the
three months ended September 30, 2000 are not necessarily indicative of the results to be
expected for the entire fiscal year.



2. EARNINGS (LOSS) PER
SHARE


Basic earnings per share have been
computed using the weighted average number of shares of common stock of the Company
(Common Stock) outstanding for each period presented. For the three months ended
September 30, 2000, common stock equivalents are not included in the calculation of loss
per share as the effect would be anti-dilutive. For the three months ended September 30,
1999, the dilutive effect of stock options and other common stock equivalents is included
in the calculation of diluted earnings per share using the treasury stock method.




3. NOTES PAYABLE TO A
RELATED PARTY


On October 11, 2000, Fratelli
Auriana, an entity controlled by Mr. Auriana, the Chairman of the Board of the Company,
committed to loan the Company up to $2,000,000, to be drawn in multiples of $250,000, as
needed by the Company, subject to the terms described as follows. Mr. Auriana has agreed
to provide funds to Fratelli Auriana should any be necessary to ensure Fratelli Auriana
meets this obligation to the Company. Interest at the rate of prime plus 1/4% will be
charged on any outstanding balance and must be paid quarterly. Any principal and interest
outstanding must be paid by September 30, 2002. Any money borrowed may be prepaid without
penalty on three days notice. Any principal and interest outstanding will become
immediately due and payable upon a change of control of the Company, which is to be
defined in final agreements between Fratelli Auriana and the Company. The loan will be
secured by all of the assets of the Company. The Company will pay Fratelli Auriana an
origination fee equal to the reasonably incurred expenses of Fratelli Auriana, including
legal fees, up to a maximum of 3/8% of $2,000,000. There will be no facility fee. In
connection with the loan from Fratelli Auriana, Mr. Auriana has agreed to defer payment
of principal and accrued interest on an existing demand loan extended by Mr. Auriana to
the Company of approximately $704,000, which with accrued interest totaled $1,236,000 and
$1,253,000 at June 30, 2000 and September 30, 2000, respectively, until the same time as
the loan from Fratelli Auriana to the Company becomes due. This earlier loan by Mr.
Auriana to the Company shall maintain its present secured position. Final terms and
conditions will be documented in a loan agreement and related documentation currently
being negotiated among Fratelli Auriana, Mr. Auriana and the Company.
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

|INDEPENDENT ACCOUNTANTS REPORT


To The Board of Directors and
Stockholders ofMediware Information Systems, Inc.



We have reviewed the accompanying
consolidated balance sheet of Mediware Information Systems, Inc. and subsidiaries as of
September 30, 2000, and the related consolidated statements of operations and
comprehensive income, and cash flows for the three month periods ended September 30, 2000
and 1999. These financial statements are the responsibility of the Companys management.


We conducted our review in
accordance with standards established by the American Institute of Certified public
Accountants. A review of interim financial information consists principally of applying
analytical procedures to financial data and making inquiries of persons responsible for
financial and accounting matters. It is substantially less in scope than an audit
conducted in accordance with generally accepted auditing standards, the objective of
which is the expression of an opinion regarding the financial statements taken as a
whole. Accordingly, we do not express such an opinion.


Based on our review, we are not
aware of any material modifications that should be made to the accompanying financial
statements for them to be in conformity with generally accepted accounting principles.


We previously audited, in accordance
with generally accepted auditing standards, the consolidated balance sheet as of June 30,
2000, and the related consolidated statements of operations and comprehensive income,
stockholders equity, and cash flows for the year then ended (not presented herein), and
in our report dated September 1, (with respect to Notes 7 and 14, October 11, 2000), we
expressed an unqualified opinion on those consolidated financial statements. In our
opinion, the information set forth in the accompanying consolidated balance sheet as of
June 30, 2000, is fairly stated in all material respects, in relation to the consolidated
balance sheet from which it has been derived.


Richard A. Eisner & Company, LLP


New York, New YorkNovember 10, 2000
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

|ITEM 2. MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


ForwardLooking
Statements


Certain statements made in or
incorporated into this 10-Q may constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995, as the same may be
amended from time to time (the Act) and in releases made by the SEC from time to time.
Such forward-looking statements are not based on historical facts and involve known and
unknown risks, uncertainties and other factors which may cause the actual results of the
Company to be materially different from any future results expressed or implied by such
forward-looking statements. These risks and uncertainties include: (i) fluctuations in
quarterly operating results, (ii) reliance on third party software, (iii) dependence on
third party marketing relationships, (iv) changes in the healthcare industry, (v)
significant competition, (vi) the Companys ability to manage its rapid growth, (vii) the
effects of government regulations on the Company, (viii) new regulations relating to
patient confidentiality, (ix) product related liabilities, (x) risks associated with
system errors and warranties. Amplification of such risks may be found in the
Managements Discussion and Analysis of Financial Condition and Results of Operations
section of the Companys Annual Report on Form 10-K for the fiscal year ended June 30,
2000. The Company does not intend to update publicly any forward-looking statements.



Results of Operations
September 30, 2000 compared to September 30, 1999


Total revenues for the quarter ended
September 30, 2000 decreased $879,000 or 12.6% from the prior years first quarter total
of $7,003,000. The decrease primarily reflected a slowdown of sales in the Blood Bank
division.


System sales decreased by 30.9% or
$717,000 from a year ago. Management believes that diminishing sales in the Companys
Blood Bank transfusion product has negatively impacted system sales. The decrease in
Blood Bank system sales was offset by a 32.6% increase in new system sales in the
Pharmacy division and a 41.1% increase in new system sales from the Operating Room divisions
newly developed suite of case management software.


Service revenues decreased by
$162,000 or 3.5% compared to prior year service revenues of $4,681,000. In the first
quarter of fiscal year 2000, service revenues were higher in preparation for anticipated
Y2K issues.


Cost of systems includes the cost of
computer hardware and sublicensed software purchased from computer and software
manufacturers by Mediware as part of its complete system offering. These costs can vary
as the mix of revenue varies between high margin proprietary software and lower margin
computer hardware and sublicensed software components. Cost of systems was 27.9% of new
system sales compared to 30.7% last year. Cost of systems decreased by 37.2% or $265,000
from $712,000 in the first quarter of 2000 principally due to the decrease in system
sales.


Cost of services includes the
salaries of client service personnel and communications expenses along with the direct
expenses of the client service function. Cost of services increased 5.6% or $89,000 to
$1,666,000 in the current year and was 36.9% of related revenues compared to 33.7% last
year. This increase is primarily related to an increase in implementation and support
personnel needed to implement and support software in the early maturity stage of the
softwares lifecycle and prepare for transitioning legacy product clients to the newest
technology.
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

|Software development costs include
salaries, contract labor, quality assurance, documentation, office and other expenses
incurred in product development along with amortization of software development costs.
Software development costs increased $294,000 or 26.2% from the same quarter last year of
$1,122,000. Total expenditures for software development, including both capitalized and
non-capitalized portions and excluding capitalized software amortization were $2,266,000
as compared to $1,834,000 in the first three months of fiscal 2000. Spending on
development has increased among all company divisions. The Company expects to continue
substantial software development expenditures for the foreseeable future to move all
product lines into current client server technology.


Selling, general and administrative
expenses include marketing and sales salaries, commissions, travel and advertising
expenses. Also included are bad debt expenses, legal, accounting and professional fees;
salaries and bonus expense for corporate, divisional, financial and administrative staff;
utilities, rent, communication and other office expenses, and other related direct
administrative expenses. Selling, general and administrative expenses increased by
$86,000 or 2.8% from $3,045,000 in the first three months of fiscal 2000 to $3,131,000 in
the same period in fiscal 2001.


Net loss for the quarter was
$310,000 compared to net earnings of $361,000 for the first quarter of fiscal 2000, or a
decrease in earnings of 193.4%.



Liquidity and Capital
Resources


As of September 30, 2000 the Company
had cash and cash equivalents of $1,679,000, a decrease of $1,955,000 from the fiscal
year end June 30, 2000. The Companys working capital deficit was $(2,483,000) and
current ratio was 0.77:1 at September 30, 2000, compared to a working capital deficit of $(1,343,000) and a
current ratio of .88:1 at June 30, 2000. The Companys net cash outflow of $512,000
from operating activities for the quarter compares to cash generated during the same
quarter in fiscal year 2000 of $1,603,000. The decrease in cash from operations and
working capital for the current quarter ended September 30, 2000, was due primarily to a
decrease in new system sales and the payment of trade accounts payable and accrued
liabilities, including the final installment payment of $375,000 for the LifeTrak product.


The principal uses of cash for investing activities during the quarter included purchases
of fixed assets and investments in product development. Fixed asset purchases of $312,000
were primarily related to the relocation of the Hemocare product center and equipment
purchased for development in the Blood Bank division. Additionally, the Company acquired
software and hardware to upgrade the Companys accounting and time-tracking systems. The
Company capitalized $1,218,000 and $866,000 of product development costs during the quarters
ended September 30, 2000 and 1999, respectively. The product development
capitalized related to continuing new development in the Pharmacy, Operating Room and Blood Bank
divisions. The Company plans to continue on a plan of investing heavily to develop all
its core product lines in current technologies.
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

|Cash generated in financing
activities for the quarter ended September 30, 2000 of $103,000 related to proceeds from
the exercise of options compared to $139,000 generated in the same period a year ago.
During the first quarter of fiscal year 2000, $150,000 was used to repay debt
obligations. No debt repayment occurred during the most recently ended quarter of fiscal
2001.



The Companys liquidity is
influenced by the Companys ability to perform on a best of breed basis in a
competitive industry that is currently impacted by consolidations of Healthcare
Information System providers. The factors that may affect liquidity are the ability
to penetrate the market with its products, maintain or reduce the length of the selling
cycle, and the ability to collect cash from clients as implementations of systems
progresses. Exclusive of activities involving any future acquisitions of products or
companies that compliment or augment the existing line of products, management believes
that current funds, cash generated from operations and a loan commitment from Fratelli
Auriana, described below, will be sufficient to meet operating requirements for the
remainder of fiscal year 2001. While the Company cannot provide assurances, new software
sales are projected to increase during fiscal year 2001 and generate sufficient cash flow
for operations. However, the weaker new software sales during fiscal year 2000 combined
with a plan to continue heavy investments in product development is expected to result in
a cash shortfall in the second or third quarter of fiscal year 2001. In October 2000, the
Company obtained from Fratelli Auriana, an entity controlled by Larry Auriana, the
Chairman of the Board of Directors of the Company, a commitment to loan the Company up to $2,000,000
as needed by the Company through September 30, 2002, when any outstanding principal and
interest will be due. The loan is collateralized by all the assets of the Company.
Contemporaneously, Mr. Auriana has agreed to defer until the same date the loan from
Fratelli Auriana is due, payment of an existing loan extended by Mr. Auriana to the
Company of approximately $704,000 plus accrued interest (principal and interest total
approximately $1.2 million) that was previously payable upon demand.



ITEM 3. QUANTITATIVE AND
QUALITATIVE DISCLOSURES ABOUT MARKET RISKS


The Company does not currently have any material exposure to foreign currency transaction gains or losses.
However, the company does have some exposure to foreign currency rate fluctuations arising from sales made to customers in the United Kingdom.  These
transactions are made by the Companys U.K. based, wholly owned subsidiary which transacts business in the local functional currency. To date, the
Company has not entered into any derivative financial instrument to manage foreign currency risk and is currently not evaluating the future use of any such financial instruments.
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

|PART II OTHER INFORMATION



ITEM 6. EXHIBITS AND
REPORTS ON FORM 8-K
|---------------------------------------------------------------------

|(a). |  | Exhibits
|---- |  | --------

|Exhibit 10.26 |  | Commitment letter from Fratelli Auriana, Inc. and Lawrence Auriana to Mediware
Information Systems, Inc. dated October 11, 2000, incorporated by reference to the
Exhibit bearing the same designation in the Companys Annual Report on Form 10-K for the
fiscal year ended June 30, 2000.
|------------- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|Exhibit 11. |  | Schedule of Computation of Net Income (Loss) Per Share
|----------- |  | ------------------------------------------------------

|Exhibit 15. |  | Letter of awareness from Richard A. Eisner & Company, LLP dated November 13, 2000
concerning unaudited interim financial information
|----------- |  | ------------------------------------------------------------------------------------------------------------------------------------

|Exhibit 27. |  | Financial Data Schedule
|----------- |  | -----------------------

|(b). |  | Reports
on Form 8-K
|---- |  | -------------------

| |  | No
reports on Form 8-K were filed by the Company during the quarter ended September 30, 2000.
| |  | ---------------------------------------------------------------------------------------------

---

|SIGNATURES



Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| |  | MEDIWARE INFORMATION SYSTEMS, INC.          (Registrant)
| |  | --------------------------------------------------------

|November 14, 2000(Date) |  | /s/ Michael Montgomery
Michael MontgomeryPresident and Chief Executive Officer
|----------------------- |  | --------------------------------------------------------------------------------------------

|November 14, 2000(Date) |  | /s/ Kerry Robison 
Kerry Robison Chief Financial and Accounting Officer
|----------------------- |  | -------------------------------------------------------------------------------------